Workshop G: The EAP Flywheel: Sequencing Expanded Access from Trial Design to Commercial Launch
3:00 pm - Monday 19th October 2026
- Learning how to position Expanded Access as a cross-functional capability across Medical, Clinical, and Commercial teams, supported by governance models that enable launch readiness while remaining compliant and patient-centric
- Exploring how patient experience and outcomes from Expanded Access can generate longitudinal insights that inform regulatory, medical, and market-access decisions across jurisdictions
- Learning a framework for determining where and when to establish Expanded Access, balancing country prioritization, patient continuity, launch sequencing, and regulatory considerations
- Discovering how EAP insights, including patient outcomes, site experience, and operational learnings, can support Medical Affairs, Market Access, HEOR, and launch planning objectives
